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____________________________________________________________________________________ 
Abstract  
Objective: To evaluate surgical variations and treatment results of parotids gland masses that require 
parotidectomy. Methodology: The study group includes patients diagnosed in ENT service of UHC 
Tirana with tumors of the parotid gland and undergone parotidectomy. We recorded all patient 
personal data, histology (benign or malignant) of the disease, FNAC reports, type of surgical 
procedure, complications, and histology of the excised masses. All data was elaborated by statistical 
analysis with SPSS version 15.0. Results: Of 96 patients treated between years 2005-2014, 47 (49%) 
were males and 49 (51%) were female, with e median age of 42=/-12.6 years old. All patients 
presented with and indolent mass around the ear. 90.47% (87) of the patients had a benign tumor, 
and 9.52% (9) had a malignant tumor. Superficial parotidectomy was performed in 79.36% (n=76) of 
the patient, total parotidectomy was performed in 19% (n=18) of the cases, and total extended 
parotidectomy was performed in 2 cases with mucoepidermoid carcinoma. The most frequent post-
operative complication was auricular major nerve palsy (n=14; 15%), followed by transitory palsy of 
the facial nerve (n=8; 9%). Conclusions: Parotid gland masses effect people of both genders. Most of 
the patients have benign disease and mostly pleomorphic adenoma. The surgical procedure performed 
more frequently is superficial parotidectomy. 
Key words: Parotid gland, superficial parotidectomy, pleomorphic adenoma, facial nerve palsy, 
mucoepidermoid carcinoma. 
_____________________________________________________________________________________ 
 
Introduction 
The parotid gland is the head and neck organ most affected by tumoral diseases. It is 
the salivary gland most affected by tumoral disease, calculated approximately around 
80%. Incidence of parotid gland masses is around 1 in 100.000 11. In 80% of the cases 
pleomorphic adenoma in encountered, while Warthin’s tumor is found in 10% of the 
cases. Of the malignant tumors the most frequent encountered is mucoepidermal 
carcinoma, followed by adenocystic carcinoma1-3. 
From 50 years, parotidectomy is performed routinely in our country without nerve 
monitoring and with no nerve complications. From our experience even though patients 
have imaging findings (like MRI), in some case (3 - 4 patients) the differential diagnose 
with parapharyngeal space tumors has been difficult. In most cases we have performed 
superficial parotidectomy, and differential diagnose with parapharyengeal space tumors 
was done intra-operatively.  
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Methodology  
This study was performed with patients presented in our ENT service of the UNH Tirana 
(University Hospital Center of Tirana) during the 2005-2014 year period, and 
underwent parotid surgery. Patients presented with other pathologies, like parotis 
abcess, and did not undergo parotidectomy, were excluded from the study. The initial 
diagnose was achieved through patient history, physical and complementary 
examinations. Patient data was gathered from their statistical record in the UHCT 
Statistics Service. Histopathology data was gathered from the Department of Anatomy 
and Pathology. Type of performed surgery depended on presurgical diagnose, FNAC, 
radiology, and clinical presentation fo the tumor. 
Superficial parotidectomy was performed in all benign tumors of the superficial lobe. 
Total parotidectomy was chosen for malignant tumors and benign tumors that 
infiltrated the deep lobe. Extended total parotidectomy was performed in locally 
advanced malignant tumors. Facial nerve identification, the V-shaped sulcus was 
located from the mastoid bone apex near the external auditory canal. 
Tympanomastoidean fissure and the trageal cartilage were the orienting points for 
nerve identification. In all cases the nerve was identified in its usual bifurcation point. 
Afterward all nerve branches were identified and dissected, and superficial 
parotidectomy was completed. In no case we used nerve monitoring for nerve 
identification. 
Patient profile, social-demographic, clinical signs at presentation, benign or malignant 
nature of the tumor, FNAC reports, type of performed surgery, and histological reports 
of the masses were taken from patients’ clinical charts. 
Data was analyzed with SPSS (Statistical Package for Social Sciences) version 15. 
Numerical data, like age, were expressed by mean +/- standard deviation, while 
categorical data, like gender distribution, histological diagnose, surgical procedure and 
complications, were expressed as frequencies and percentage. Two tables were used to 
summarize the data. 
Results 
Of 126 patients, 51% (n=49) were female and 49% (n=47) male. Age varied from 15 -
65 years old. Most of the patients (63%) were in the third and fourth decade of life. 
Median age was 43 +/- 9.2 yrs old. 
The most frequent clinical sign at presentation was the presence of a mass round the 
ear, which was present in all patients. Other signs were facial nerve palsy in 3% (n=3) 
and pain in 2% (n=2) of the cases. If all patients, 90.47% (n=87) had benign disease, 
and 9.52% (n=9) had malignant tumor. The deep lobe was involved in 2% (n=2) of the 
case, while 8% (n=8) had recurrent swelling. Table 1 shows the histological diagnose of 
the surgically excised masses. 
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Table 1: Histopathological diagnose in all patients (n=96) 
DIAGNOSE NUMBER OF PATIENTS 
Pleomophic adenoma 80(83.33%) 
Mucoepidermoid carcinoma 6(6.25%) 
Warthin’s tumor 4(4.16%) 
Xiphilic adenoma 2(2.08%) 
Adenoid cystic carcinoma 2(2.08%) 
Ex-pleomorphic adenoma carcinoma 2(2.08%) 
 
Postsurgical complication include auricular major nerve paresis, in 15% (n=19) of the 
cases, facial nerve paresis in 8% (n=8), facial nerve palsy in 4.76% (n=5), Frey’s 
syndrome in 2.1% (n=2). The diagnostic value of FNAC was evaluated and has a 
specificity of 98.24%, and sensitivity of 83.35%. Diagnostic accuracy is 96.82%. (Table 
2) 
Table 2: Calculation of the diagnostic accuracy of FNAC in the diagnose of 
malignant tumors of the parotid gland 
                                 FNAC  
 
 
Total  
Positive for  
malignancy 
Negative for 
malignancy 
Histology positive for  
malignancy 
8 2 10 
Histology negative for  
malignancy 
1 85 86 
Total  9 87 96 
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Discussion 
This study was focused on parotid gland tumors, which is the most salivary gland 
affected by tumoral diseases. It is involved by a variety of different benign and 
malignant conditions for which a wide range of surgical procedures are available8,9,10. 
The present study is one the largest reported local series on parotid gland disorders 
from Albania. In this study, the mean age for parotid gland disorders was 41 years 
confirming to several published studies 9, 12, and 13. However, several studies from 
the West have reported these disorders to be more common in relatively advanced 
groups1,2. In this study, there was a slight female predominance. Several published 
studies have reported similar more frequent involvement of females than males. 
In this study, pleomorphic adenoma constituted the commonest pathology affecting the 
parotid gland. Most of the publishing literature has reported pleomorphic adenoma to 
be the commonest pathology afflicting the parotid gland5,7,16. Share of malignancies 
was about 9.52%. Different studies have reported variable percentage of malignancies 
in their patients. Onder et al. have reported 24% malignancies in their parotid gland 
disorders15. Takahama et al. have reported even higher frequency of malignancies at 
40% 1. In this series the commonest malignant tumor was mucoepidermoid carcinoma 
followed by adenoid cystic carcinoma. These findings conform to what is reported by 
most of the published literature5, 15, and 17. 
In this study, FNAC was found to be very useful for diagnosing malignancies of the 
parotid gland. It was found to have 98.24% specificity and 83.33% sensitivity. It is 
economical and easy to perform in parotid swelling. These findings conform to what is 
reported by Cohen et al. who have reported similar diagnostic accuracy of FNAC in 
parotid gland tumors7. . Dissemination of tumor cells with FNAC is a theorical risk and 
is a theorical risk and is not supported by any published data. 
In this study, the facial nerve transient paresis occurred in 8% cases while 4.76% cases 
had facial nerve palsy. These finding conforms to most of the reported studies however, 
some studies have reported as high frequency as 39% of these complications 11, 12, 
13. These uses of nerve stimulators, staining methods and other techniques have been 
explained in literature for safeguarding the nerve and these may help to reduce the 
frequency of such disabling complications. 
In our clinical practice we have encountered great variation in facial nerve trunk and 
branches anatomy, this in many cases has made nerve identification more difficult.  
 
 
 
International Journal of Medicine & Healthcare 
Vol. 2, No. 1, 2016, pp. 17-22 
www.ijmh.ielas.org                                                                                                                                           
ISSN: 2545-4188 (Online) 
 
21 
 
Conclusions 
Parotid gland tumors commonly affect relatively young individuals of either gender. 
Majority of the patients present as a painless lump in parotid region. Most of the 
patients have benign pathology while a small percentage has malignancy. Superficial 
parotidectomy is the most commonly offered surgical procedure. Parotid surgeries are 
safely performed in general surgery units with low morbidity and no mortality. 
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